KPTI

Karyopharm Therapeutics (KPTI)

About Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Details

Daily high

$6.80

Daily low

$6.33

Price at open

$6.68

52 Week High

$12.45

52 Week Low

$3.51

Market cap

114.4M

Dividend yield

0.00%

Volume

148,543

Avg. volume

178,517

P/E ratio

-.46

Karyopharm Therapeutics News